A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105
Status:
Completed
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety, tolerability, and PK following single and
multiple ascending dose administration of VS-105 in healthy subjects and patients with
chronic kidney disease stage 5D (CKD-5D) on hemodialysis.